The following categories are used to indicate the frequency of occurrence of adverse effects: Very common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000); Unknown (Frequency not assessable based on the available data).
They are presented in the table as follows: (See table.)
Click on icon to see table/diagram/image
Swelling face and allergic reactions, including application site hypersensitivity and anaphylaxis (unknown frequency) have been reported during post-marketing surveillance.
View ADR Monitoring Form